Han Ma, MD, PhD

BeiGene USA, Inc.

n/a

Poster(s):

• 2014 - Characterization of the safety/tolerability profile of zanubrutinib and comparison with the profile of ibrutinib in patients with B-cell malignancies: post hoc analysis of a large clinical trial safety database